Enlivex Ltd. - (ENLV) closed at $1.20 on November 18, 2026, up 4.3% from the previous close, on volume of 38,636 shares (30-day average 1,557,830).
Data as of November 18, 2026.
Enlivex Reports DSMB Review Allows Continued Enrollment in Phase IIb Knee OA Trial
TipRanks (Wed, 18-Nov 8:31 AM ET)
Globe Newswire (Wed, 18-Nov 8:00 AM ET)
Enlivex Reports Initial Closing of Registered Direct Offering
TipRanks (Tue, 17-Nov 5:25 PM ET)
Enlivex Announces Dec. 4 Extraordinary Meeting on Authorized Share Capital
TipRanks (Tue, 17-Nov 5:01 PM ET)
Enlivex prices $7.5M registered direct offering
Seeking Alpha News (Mon, 16-Nov 8:42 AM ET)
Enlivex Announces Pricing of $7.5 Million Registered Direct Offering
TipRanks (Mon, 16-Nov 8:40 AM ET)
Globe Newswire (Mon, 16-Nov 8:00 AM ET)
Globe Newswire (Mon, 2-Nov 8:00 AM ET)
Globe Newswire (Wed, 28-Oct 8:00 AM ET)
Enlivex Announces Receipt of Delisting Notice from Nasdaq; Intends to Appeal
Globe Newswire (Tue, 27-Oct 8:00 AM ET)
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Enlivex Ltd. - trades on the NASDAQ stock market under the symbol ENLV.
As of November 19, 2026, ENLV stock price climbed to $1.24 with 57,680 million shares trading.
ENLV has a beta of 1.26, meaning it tends to be more sensitive to market movements. ENLV has a correlation of 0.02 to the broad based SPY ETF.
ENLV has a market cap of $1.90 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, ENLV traded as high as $1,101.60 and as low as $1.00.
ENLV has underperformed the market in the last year with a price return of -99.5% while the SPY ETF gained +11.0%. ENLV has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -94.9% and -10.8%, respectively, while the SPY returned -5.3% and -5.4%, respectively.
ENLV support price is $1.07 and resistance is $1.33 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ENLV shares will trade within this expected range on the day.